companydata.dkcompanydata.dk

NORDIC BIOTECH K/S: Financial statements 2022

CVR: 26290724

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -44,572,000 compared with DKK -6,387,000 the year before. Equity in the 2022 report amounted to DKK 34,150,000. The solvency ratio was 99.8%.

Profit/Loss
DKK -44,572,000
Equity
DKK 34,150,000
Total Assets
DKK 34,208,000
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022---44.6M34.2M0
2021---6.4M78.7M0
2020---1.4M85.1M0
2019--13M86.5M0
2018---464.7M73.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on NORDIC BIOTECH K/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

NORDIC BIOTECH K/S: The 2021 annual report is outMay 18, 2022

NORDIC BIOTECH K/S has published its annual report for 2021. The net result was DKK -6,387,000.

About NORDIC BIOTECH K/S

NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.

Source: annual report 2024, Danish Business Authority